The DOI matches its Crossref record.
Natural Products in the Process of Finding New Drug Candidates
Abstract
Natural derived or originated compounds still play a major role as drugs, and as lead structures for the development of synthetic molecules. About 50% of the drugs introduced to the market during the last 20 years are derived directly or indirectly from small biogenic molecules. In the future, natural products will continue to play a major role as active substances, model molecules for the discovery and validation of drug targets. A multidisciplinary approach to drug discovery involving the generation of truly novel molecular diversity from natural product sources, combined with total and combinatorial synthetic methodologies provides the best solution to increase the productivity in drug discovery and development. Screening for new drugs in plants implies the screening of extracts for the presence of novel compounds and an investigation of their biological activities. It is currently estimated that approximately 420,000 plant species exist in nature. For the purpose of lead discovery, or for the scientific validation of a traditional medicinal plant or a phytopharmaceutical, active principals in complex matrices need to be identified. Therefore, the interfacing of biological and chemical assessment becomes the critical issue. Drug discovery from plants can be guided by epidemiologic studies facilitated with computer assisted HPLC microfractionation and microplate technology. Epidemiologic studies have shown that high dietary flavonoid intake may be associated with decreased risk for cardiovascular disease. Chlamydia pneumoniae is a common human pathogen and epidemiological and clinical studies have shown a connection between chronic C. pneumoniae infection, atherosclerosis and the risk of myocardial infarction. We will present here the detection of natural compounds active against C. pneumoniae as an example.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Thymoquinone: A promising anti-cancer drug from natural sources
Gali-Muhtasib, H., Roessner, A., & Schneider-Stock, R. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.10.009 · Cited by 420
Plant natural products: Back to the future or into extinction?
McChesney, J. D., Venkataraman, S. K., & Henri, J. T. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.04.032 · Cited by 377
Rice bran nutraceutics: A comprehensive review
Sohail, M., Rakha, A., Butt, M. S., Iqbal, M. J., & Rashid, S. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1164120 · Cited by 256
Bitter apricot essential oil induces apoptosis of human HaCaT keratinocytes
Li, K., Yang, W., Li, Z., Jia, W., Li, J., Zhang, P., & Xiao, T. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.02.019 · Cited by 28
“For centuries plant extracts have been used in the identification and research of potential new drugs [7], and during the last decade, there has been a remarkable and growing interest in using plant extracts, as alternative medicines, for the management of psoriasis.”
Background
Metadata
- Authors
- Vuorela, P., Leinonen, M., Saikku, P., Tammela, P., Rauha, J., Wennberg, T., & Vuorela, H.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2004-06-01
- Volume
- 11
- Issue
- 11
- Pages
- 1375-1389
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2129605627
- Cited by
- 323
- References
- 0
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.